2021 CMSC Annual Meeting

Tag: WA

Poster-Neurophysiology; Neuropsychology and Neuropsychiatry

Identifying Prospective Memory Deficits in MS with a Single Task from the Memory for Intentions Test: An IRT and ROC Analysis

Background: While many persons with multiple sclerosis (PwMS) have prospective memory (PM) issues, which can have an impact on everyday...

Read More

Poster-Disease-modifying Therapy

Real-Life Experience with Ocrelizumab in Older Patients at an Academic MS Center

Background: Ocrelizumab (OCR) is a B-Cell depleting humanized monoclonal antibody FDA-approved for treatment of relapsing remitting...

Read More

Platform-Disease Modifying Therapies

Efficacy and Safety of Ublituximab Versus Teriflunomide in Relapsing Multiple Sclerosis: Results of the Phase 3 Ultimate I and II Trials

Background: Ublituximab, a novel monoclonal antibody, targets a unique epitope on the CD20 antigen and is glycoengineered for enhanced...

Read More